DAM, first described in Alzheimer’s disease models, are characterized by downregulation of homeostatic markers like P2RY12 and CX3CR1, and upregulation of Trem2, Apoe, Axl, and Spp1. This evidence concerns the gene TREM2 and Alzheimer disease.